The Path Raises $14.3M Seed to Scale AI Therapy Platform Built for Men's Mental Health
The Path, an AI-powered mental health platform explicitly tailored to men, has closed a $14.3 million seed round led by Prime Movers Lab — one of the largest men's mental health seed raises of the year, backed by athlete investors and Tony Robbins.
FUNDRAISE
Editor
5/26/20261 min read
The Path, a digital mental health startup focused specifically on the barriers men face in seeking psychological support, has raised $14.3 million in seed funding. Prime Movers Lab led the round, with participation from Olympic gold medalist Apolo Anton Ohno, heavyweight boxing champion Deontay Wilder, and Designer Fund. The company was co-founded with the involvement of Tony Robbins, the motivational speaker and wellness entrepreneur — a co-founder whose profile carries significant reach into the male consumer demographic the platform targets.
The Path offers an AI-driven therapy experience designed to meet men where they are, addressing the specific reasons men disengage from traditional mental health services: the format of conventional therapy, the stigma around disclosure, and the absence of credible male role models normalising help-seeking behaviour. The platform delivers AI-guided therapeutic sessions tailored to men's wellbeing challenges, sitting at the intersection of consumer wellness and clinical digital health.
The $14.3 million seed round represents meaningful conviction capital for the category. The athlete investors — Ohno and Wilder — bring aspirational identity appeal for the target user base, a deliberate positioning decision. No revenue figures or active user counts were disclosed in available coverage. Prime Movers Lab has a track record of backing companies that address foundational human challenges; its lead position signals a view that the male mental health gap is both large and underserved by existing platforms.
The raise signals growing investor recognition that men's mental health warrants a standalone investment thesis rather than a sub-feature of general telehealth. The Path's co-founder profile and athlete investor base mark a consumer-brand-first approach — using masculine role models to lower the perceived cost of engagement. In a category where stigma has historically been the primary barrier to adoption, this positioning may prove more durable than clinical-first alternatives.